Alivus Life Sciences Limited (BOM:543322)
India
· Delayed Price · Currency is INR 953.55
-2.45 (-0.26%)
At close: Aug 14, 2025
Alivus Life Sciences Revenue
Alivus Life Sciences had revenue of 6.02B INR in the quarter ending June 30, 2025, with 2.25% growth. This brings the company's revenue in the last twelve months to 24.00B, up 4.65% year-over-year. In the fiscal year ending March 31, 2025, Alivus Life Sciences had annual revenue of 23.87B with 4.54% growth.
Revenue (ttm)
24.00B
Revenue Growth
+4.65%
P/S Ratio
4.83
Revenue / Employee
10.89M
Employees
2,014
Market Cap
115.82B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |